Bioreactors and Fermenters Market, By Type (Single-use Bioreactors, and Multiple-use Bioreactors), By Process (Fed batch, Continuous, and Batch), By End User (Biopharmaceutical companies, CROs, and Academic & Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The need for single-use bioreactors is growing.

One of the key drivers of the market's growth during the projection period is the rising demand for single-use bioreactors. This can be explained by several advantages that come with using single-use bioreactors. Compared to stainless steel bioreactors, they are easier to operate and are readily arranged for continuous processing. Additionally, single-use bioreactors minimize cleanroom space requirements and maintenance expenses. This is because, unlike conventional stainless-steel bioreactors, they do not require the same utility and piping infrastructure. Numerous advantages are fueling the market expansion for fermenters and bioreactors.

R&D in biopharmaceuticals is rising.

The growing geriatric population is driving up demand for biopharmaceuticals globally, as they are more susceptible to various diseases. Businesses focusing on biopharmaceutical R&D are expanding their manufacturing for development and production in anticipation of this demand. The biopharmaceutical industry invests six times more in R&D per dollar sales than other manufacturing industries. The biopharmaceutical company estimated it spent USD 102 billion on research and development in 2018. Workflows used in the production of biopharmaceuticals must include single-use technologies. They produce excessive small- and mid-scale biopharmaceutical manufacturing, especially for R&D and clinical testing.